Home › Prostate Cancer › Florida
Prostate Cancer clinical trials in Florida
100 studies for Prostate Cancer are looking for participants at sites in Florida.
Cities in Florida
- Miami30 studies
- Jacksonville25 studies
- Tampa18 studies
- Orlando18 studies
- Gainesville8 studies
- Miami Beach6 studies
- Sarasota6 studies
- Coral Springs5 studies
- Hialeah5 studies
- Plantation5 studies
- Hollywood5 studies
- Deltona4 studies
- West Palm Beach3 studies
- Fort Lauderdale3 studies
- St. Petersburg3 studies
- Deerfield Beach3 studies
- Largo3 studies
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Tampa
- and 1 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 13, 2026 · NCT04423211Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Holy Cross Hospital, Fort Lauderdale
- Orlando Health Cancer Institute, Orlando
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03866382Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- University of Miami, Miami
- AdventHealth, Orlando
- Advanced Urology Institute, Oxford
Recruiting
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT06511141Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer
- Mayo Clinic in Florida, Jacksonville
RecruitingPhase 2
Ages 18 and older · Men · Updated Nov 6, 2026 · NCT07073794WATER IV PCa (AS Sub-study)
- Advanced Research, Delray Beach
- University of Miami, Miami
- Trophy Point Urology, Tampa
Recruiting
Ages 45 and older · Men · Updated Nov 6, 2026 · NCT07650448A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
- University of Florida, Gainesville
- Mayo Clinic in Florida, Jacksonville
- University of Miami, Miami
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Nov 5, 2026 · NCT05655494Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
- Morton Plant Hospital, Clearwater
- and 11 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Nov 4, 2026 · NCT05334069A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Moffitt, Tampa
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07114601Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Jupiter Medical Center, Jupiter
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06632977A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
- SSAK Partners, LLC, Coral Springs
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT07723248A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
- Florida Cancer Specialists & Research Institute, Sarasota
RecruitingPhase 1
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT07746713Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Malcom Randall Veterans Administration Medical Center, Gainesville
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT06931340Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Florida Cancer Specialists, Sarasota
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT06800313A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
- Florida Cancer Specialists, Sarasota
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07319871A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
- Advanced Urology Institute, Largo
RecruitingPhase 2
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT07832292A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
- Florida Cancer Specialists, Sarasota
RecruitingPhase 1
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT07082920A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
- Sarah Cannon Research Institute @ Florida Cancer, Orlando
RecruitingPhase 1
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT05800665Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
- Desai Sethi Urology Institute, Miami
- Sylvester Comprehensive Cancer Center, Miami
RecruitingPhase 4
Ages 18 and older · Men · Updated Nov 2, 2026 · NCT07278362A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Biogenix Molecular, LLC, Miami
RecruitingPhase 1
Ages 18 and older · Men · Updated Nov 2, 2026 · NCT07581184A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors
- Biogenix Molecular, LLC, Miami
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07887971A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Clermont Oncology Center ( Site 0087), Clermont
- Mayo Clinic in Florida-Mayo Clinic Comprehensive Cancer Center ( Site 0077), Jacksonville
- Mid Florida Hematology and Oncology Center ( Site 0086), Orange City
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 30, 2026 · NCT06925737Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Mayo Clinic, Jacksonville
RecruitingPhase 1
Ages 18 to 100 · Men · Updated Oct 29, 2026 · NCT05519449A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06172478Exercise-induced Steroid Changes in Active Surveillance for Prostate Cancer
- University of Miami Hospitals and Clinics, Miami
Recruiting
Ages 18 to 80 · Men · Updated Oct 23, 2026 · NCT07518888Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- Bay Pines VA Healthcare System, Bay Pines
- AdventHealth Daytona Beach, Daytona Beach
- and 9 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 23, 2026 · NCT05946213A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 118, Celebration
- Research Site 127, Margate
- Research Site 137, Orlando
- and 2 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT05914116A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Sylvester Comprehensive Cancer Center, Miami
- Hematology Oncology Associates of the Treasure Coast, Port Saint Lucie
RecruitingPhase 1
Ages 18 and older · Men · Updated Oct 20, 2026 · NCT07103018A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Mount Sinai Braman Comprehensive Cancer Center ( Site 0107), Miami Beach
- Memorial Hospital West-Memorial Cancer Institute ( Site 0109), Pembroke Pines
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT06136650A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Moffitt Cancer Center, Tampa
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 20, 2026 · NCT07213674AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Miami
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 19, 2026 · NCT07611110A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Research Site, Miami
- Research Site, Tampa
RecruitingPhase 1
Ages 18 and older · Men · Updated Oct 16, 2026 · NCT06879041Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT06239194Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
- Research Site, Margate
- Research Site, Miami
- Research Site, Orlando
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 15, 2026 · NCT07711002Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Florida Cancer Specialists, Fort Myers
- Baptist Health South, Miami
- AdventHealth, Orlando
RecruitingPhase 3
Ages 18 to 100 · Men · Updated Oct 15, 2026 · NCT06855277Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Research Site, Miami
- Research Site, Orlando
- Research Site, Tampa
RecruitingPhase 1/2
Ages 18 to 99 · Men · Updated Oct 14, 2026 · NCT07590934A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Hialeah
- Research Site, Jacksonville
- Research Site, Tampa
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 14, 2026 · NCT06952803This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Advanced Urology Institute, LLC, Largo
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 14, 2026 · NCT07028853Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
- Mayo Clinic in Florida, Jacksonville
RecruitingEarly phase 1
Ages 18 and older · Men · Updated Oct 13, 2026 · NCT05045066Exploring the Potential of Robotic Telesurgery in Remote Settings
- AdventHealth, Celebration
Recruiting
Ages 18 to 90 · Men · Updated Oct 8, 2026 · NCT07130708Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- and 5 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 8, 2026 · NCT03678025From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.